INmune Bio Inc (NASDAQ:INMB) is set to release its Q1 2025 earnings on May 8, 2025. The consensus estimate for Q1 2025 revenue is $0.00 million, and the earnings are expected to come in at -$0.47 per ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Boca Raton, July 29, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) announced today that a video detailing the additional findings from the Phase 2 MINDFuL trial evaluating XPro™, a novel ...
Global Experts in MSC Clinical Translation to Advise Ebstrocel™ Regulatory and Clinical Development and Guide Expansion of CORDStrom Product ...
Management to host conference call and webcast at 4:30 pm ET on that dayBOCA RATON, Fla, July 31, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc.
Image source: The Motley Fool. INmune Bio (NASDAQ:INMB) highlighted its transition toward late-stage regulatory submissions, with CORDStrom's RDEB application preparations now in the advanced phase ...
OmniScience and INmune Bio (INMB) announced a partnership to revolutionize operations for INmune Bio’s global Phase 2 Alzheimer’s disease, or AD, clinical trial using OmniScience’s product, Vivo, a ...
Fintel reports that on August 22, 2024, Scotiabank initiated coverage of INmune Bio (NasdaqCM:INMB) with a Sector Outperform recommendation. As of August 6, 2024, the average one-year price target for ...
Greetings, and welcome to the INmune Bio Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the ...
A downtrend has been apparent in INmune Bio, Inc. (INMB) lately. While the stock has lost 11.9% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in its ...
Image source: The Motley Fool. INmune Bio (NASDAQ:INMB) delivered an update signaling concrete progress across its CORDStrom and XPro platforms, as well as disciplined financial management. Regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results